Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Docetaxel|DRUG: 5-fluorouracil|DRUG: Doxorubicin|DRUG: Cyclophosphamide
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Sanofi